Literature DB >> 1756483

Karyotyping of a hematologic neoplasia developing shortly after treatment for cerebral extragonadal germ cell tumor.

K Heimdal1, S A Evensen, S D Fosså, H Hirscberg, R Langholm, A Brøgger, P Møller.   

Abstract

Hematologic malignancies may be associated with mediastinal extragonadal germ cell tumors. It may be that the hematologic malignancy is a part of the natural history of the teratoma, one germ cell tumor line being able to differentiate into hematological cells, or the hematologic malignancy is related to the treatment, or the two malignancies develop independently. Cytogenetic analysis of bone marrow from a patient with a germ cell tumor in the brain and the almost simultaneous appearance of a hematologic neoplasia showed a rearranged karyotype in that all 15 analyzed cells had the same karyotype: 50,XY, +X, +del(1)(p21), +10, +11, -12, +der(12)t(12;?)(q?;?). Our findings were consistent with the interpretation that the hematologic malignancy was derived from the germ cell tumor.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1756483     DOI: 10.1016/0165-4608(91)90187-y

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  4 in total

Review 1.  Acute leukemia following treatment of malignant glioma.

Authors:  J R Perry; M T Brown; J P Gockerman
Journal:  J Neurooncol       Date:  1998-10       Impact factor: 4.130

Review 2.  Second cancer after treatment of malignant germ-cell tumors.

Authors:  S D Fosså; E H Wanderås; K Heimdal
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

3.  Histochemical in situ identification of bovine embryonic blood cells reveals differences to the adult haematopoietic system and suggests a close relationship between haematopoietic stem cells and primordial germ cells.

Authors:  Michaela Kritzenberger; Karl-Heinz Wrobel
Journal:  Histochem Cell Biol       Date:  2004-02-24       Impact factor: 4.304

4.  Primary CNS teratocarcinoma.

Authors:  Danilo Vitorovic; Jordan Rosenblum; Chinnamma Thomas; John Lee; José Biller
Journal:  Front Neurol       Date:  2012-02-06       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.